ANG Lifesciences

{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "37.97",
    "chg": 0.74,
    "chgp": "1.99%",
    "dir": 1,
    "prev_price": "37.23",
    "mcapval": "49.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE236W01016",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "04:34 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "8.28 k",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4196866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ANGLifesciences_mojoScore_4196866.png",
        "date": "2026-09-18 08:15:20",
        "description": "ANG Lifesciences India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 17 Sep 2026, driven primarily by improved technical indicators. However, the company’s financial health and valuation metrics remain weak, reflecting ongoing operational challenges and elevated risk for investors."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-4162567",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ANGLifesciences_mojoScore_4162567.png",
        "date": "2026-08-20 10:10:22",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4137938",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ANGLifesciences_mojoScore_4137938.png",
        "date": "2026-08-05 10:10:03",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4115147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ANGLifesciences_mojoScore_4115147.png",
        "date": "2026-07-22 10:10:32",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4096418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ANGLifesciences_mojoScore_4096418.png",
        "date": "2026-07-10 10:10:04",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-sell-4077000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_mojoScore_4077000.png",
        "date": "2026-06-29 10:10:05",
        "description": "ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts ANG Lifesciences India Ltd to 52-Week High of Rs 49.69",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-hits-new-52-week-high-at-rs4969-4072801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_priceRelatedfactors_4072801.png",
        "date": "2026-06-25 09:56:17",
        "description": "Surging past its previous peaks, ANG Lifesciences India Ltd reached a fresh 52-week high of Rs 49.69 on 25 Jun 2026, marking a remarkable rally of 73.68% over the past year against the Sensex’s decline of 6.33%. This milestone caps a three-day winning streak that has delivered a 62.24% return, fuelled by a confluence of strong technical signals and sustained price momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts ANG Lifesciences India Ltd to 52-Week High of Rs 41.41",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-hits-new-52-week-high-at-rs4141-4070516",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ANGLifesciences_priceRelatedfactors_4070516.png",
        "date": "2026-06-24 12:11:01",
        "description": "With a surge to Rs 41.41 on 24 Jun 2026, ANG Lifesciences India Ltd has reached a fresh 52-week high, marking a 46.74% gain over the past year and significantly outperforming the Sensex, which declined 6.28% in the same period. This milestone reflects a powerful alignment of technical indicators and sustained price momentum."
      }
    ],
    "total": 312,
    "sid": "1002820",
    "stock_news_url": "https://www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Intimation Of 20Th Annual General Meeting",
      "datetime": "07-Sep-2026",
      "details": "Intimation of 20th Annual General Meeting",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 20Th AGM Of The Company On Wednesday 30Th September 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM).",
      "datetime": "07-Sep-2026",
      "details": "Notice of 20th AGM",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Intimation Of AGM",
      "datetime": "07-Sep-2026",
      "details": "This is to inform you pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the Board of Directors of the Company at its meeting held today i.e. Monday September 07 2026 inter alia has taken the following decisions:- 1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31 2026 under section 134 of the Companies Act 2013. 2. The Board of Directors of the Company have considered and approved the Notice of 20th Annual General Meeting of the Company. 3. The Board has approved the day date time and calendar of events and Notice of 20th Annual General Meeting of the company to be held on 30th September 2026 at 12:00 noon through Video Conferencing (VC)/Other Audio Visual Means (OAVM) * other details as per attachment*",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ANG Lifesciences India Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-09-18 08:15:20

ANG Lifesciences India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 17 Sep 2026, driven primarily by improved technical indicators. However, the company’s financial health and valuation metrics remain weak, reflecting ongoing operational challenges and elevated risk for investors.

Read full news article

ANG Lifesciences India Ltd is Rated Strong Sell

2026-08-20 10:10:22

ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-08-05 10:10:03

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-07-22 10:10:32

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with the latest insights into the company's performance and outlook.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-07-10 10:10:04

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

ANG Lifesciences India Ltd is Rated Sell

2026-06-29 10:10:05

ANG Lifesciences India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Broad-Based Technical Strength Lifts ANG Lifesciences India Ltd to 52-Week High of Rs 49.69

2026-06-25 09:56:17

Surging past its previous peaks, ANG Lifesciences India Ltd reached a fresh 52-week high of Rs 49.69 on 25 Jun 2026, marking a remarkable rally of 73.68% over the past year against the Sensex’s decline of 6.33%. This milestone caps a three-day winning streak that has delivered a 62.24% return, fuelled by a confluence of strong technical signals and sustained price momentum.

Read full news article

Broad-Based Technical Strength Lifts ANG Lifesciences India Ltd to 52-Week High of Rs 41.41

2026-06-24 12:11:01

With a surge to Rs 41.41 on 24 Jun 2026, ANG Lifesciences India Ltd has reached a fresh 52-week high, marking a 46.74% gain over the past year and significantly outperforming the Sensex, which declined 6.28% in the same period. This milestone reflects a powerful alignment of technical indicators and sustained price momentum.

Read full news article

View All News